OBJECTIVE: To describe how clinicians use decision aids. BACKGROUND: A 98-patient factorial-design randomized trial of the Statin Choice decision vs. standard educational pamphlet; each participant had a 1:4 chance of receiving the decision aid during the encounter with the clinician resulting in 22 eligible encounters. DESIGN: Two researchers working independently and in duplicate reviewed and coded the 22 encounter videos. SETTING AND PARTICIPANTS: Twenty-two patients with diabetes (57% of them on statins) and six endocrinologists working in a referral diabetes clinic randomly assigned to use the decision aid during the consultation. MAIN OUTCOME MEASURES: Proportion and nature of unintended use of the Statin Choice decision aid. RESULTS: We found eight encounters involving six clinicians who did not use the decision aid as intended either by not using it at all (n = 5; one clinician did use the decision aid in three encounters), offering inaccurate quantitative and probabilistic information about the risks and benefits of statins (n = 2), or using the decision aid to advance the agenda that all patients with diabetes should take statin (n = 1). Clinicians used the decision aid as intended in all other encounters. CONCLUSIONS: Unintended decision aid use in the context of videotaped encounters in a practical randomized trial was common. These instances offer insights to researchers seeking to design and implement effective decision aids for use during the clinical visit, particularly when clinicians may prefer to proceed in ways that the decision aid apparently contradicts.
RCT Entities:
OBJECTIVE: To describe how clinicians use decision aids. BACKGROUND: A 98-patient factorial-design randomized trial of the Statin Choice decision vs. standard educational pamphlet; each participant had a 1:4 chance of receiving the decision aid during the encounter with the clinician resulting in 22 eligible encounters. DESIGN: Two researchers working independently and in duplicate reviewed and coded the 22 encounter videos. SETTING AND PARTICIPANTS: Twenty-two patients with diabetes (57% of them on statins) and six endocrinologists working in a referral diabetes clinic randomly assigned to use the decision aid during the consultation. MAIN OUTCOME MEASURES: Proportion and nature of unintended use of the Statin Choice decision aid. RESULTS: We found eight encounters involving six clinicians who did not use the decision aid as intended either by not using it at all (n = 5; one clinician did use the decision aid in three encounters), offering inaccurate quantitative and probabilistic information about the risks and benefits of statins (n = 2), or using the decision aid to advance the agenda that all patients with diabetes should take statin (n = 1). Clinicians used the decision aid as intended in all other encounters. CONCLUSIONS: Unintended decision aid use in the context of videotaped encounters in a practical randomized trial was common. These instances offer insights to researchers seeking to design and implement effective decision aids for use during the clinical visit, particularly when clinicians may prefer to proceed in ways that the decision aid apparently contradicts.
Authors: Annie LeBlanc; Kari L Ruud; Megan E Branda; Kristina Tiedje; Kasey R Boehmer; Laurie J Pencille; Holly Van Houten; Marc Matthews; Nilay D Shah; Carl R May; Barbara P Yawn; Victor M Montori Journal: BMC Health Serv Res Date: 2012-05-28 Impact factor: 2.655
Authors: Laurie J Pencille; Megan E Campbell; Holly K Van Houten; Nilay D Shah; Rebecca J Mullan; Brian A Swiglo; Maggie Breslin; Rebecca L Kesman; Sidna M Tulledge-Scheitel; Thomas M Jaeger; Ruth E Johnson; Gregory A Bartel; Robert A Wermers; L Joseph Melton; Victor M Montori Journal: Trials Date: 2009-12-10 Impact factor: 2.279
Authors: Kirk D Wyatt; Megan E Branda; Ryan T Anderson; Laurie J Pencille; Victor M Montori; Erik P Hess; Henry H Ting; Annie LeBlanc Journal: Implement Sci Date: 2014-02-22 Impact factor: 7.327
Authors: Brittany C Kimball; Katherine M James; Kathleen J Yost; Cara A Fernandez; Ashok Kumbamu; Aaron L Leppin; Marguerite E Robinson; Gail Geller; Debra L Roter; Susan M Larson; Heinz-Josef Lenz; Agustin A Garcia; Clarence H Braddock; Aminah Jatoi; María Luisa Zúñiga de Nuncio; Victor M Montori; Barbara A Koenig; Jon C Tilburt Journal: BMC Cancer Date: 2013-10-04 Impact factor: 4.430